Newborns Jaundice And Cerebral Palsy

Newborns Jaundice And Cerebral Palsy.
Newborns with significant jaundice are not promising to blossom a rare and life-threatening type of cerebral palsy if American Academy of Pediatrics' treatment guidelines are followed, according to a unfledged study. Jaundice is yellowing of the eyes and skin due to high levels of the liver-produced pigment bilirubin. In most cases, jaundice develops middle newborns because their liver is too new to break down the pigment quickly enough prescription. Usually, this condition resolves without treatment.

Some babies, however, must be told phototherapy. Exposure to special lights changes bilirubin into a compound that can be excreted from the body, according to the researchers. If phototherapy fails, a conduct called exchange transfusion may be required. During this invasive procedure, the infant's blood is replaced with benefactor blood site here. Recommendations for exchange transfusions are based on bilirubin level, the mature of the infant and other risk factors for brain damage.

Exchange transfusion isn't without risk. Potential complications from the curing include blood clots, blood compel instability, bleeding and changes in blood chemistry, according to the researchers. High bilirubin levels are also risky. They've been associated with a not joking form of cerebral palsy called kernicterus. In sort to investigate this association, researchers from the University of California, San Francisco and the Kaiser Permanente Northern California Division of Research examined information from two groups of more than 100000 infants.